Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 5/20 | 0.48 |
| ▸ | ACE | P12821 | 5/20 | 0.48 |
| ▸ | CPA1 | P15085 | 2/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | PCNA | P12004 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL188399 | 1.00 | FOLH1 (0.49) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL28520123 | 0.98 | FOLH1 (0.48) | FOLH1NAALAD2MMEACECPA1 | |
| Carbamic Acid SCHEMBL7215414 | 0.96 | SLC7A5 (0.46) | FOLH1NAALAD2MMEACECPA1 | |
| Sulfuric Acid SCHEMBL8910593 | 0.94 | MEN1 (0.48) | FOLH1NAALAD2MMEACECPA1 | |
| Sulfuric Acid SCHEMBL8910597 | 0.94 | MEN1 (0.48) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL3105902 | 0.91 | FOLH1 (0.56) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL55971 | 0.91 | FOLH1 (0.56) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL55972 | 0.91 | FOLH1 (0.56) | FOLH1NAALAD2MMEACECPA1 | |
| Methane SCHEMBL4610737 | 0.89 | FOLH1 (0.55) | FOLH1NAALAD2MMEACECPA1 | |
| SCHEMBL28732225 | 0.86 | FOLH1 (0.50) | FOLH1NAALAD2MMEACECPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1605 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684002-A2 | THYROCYTES AND USES THEREOF | Lifenet Health (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250345488-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-11-13 | — | — | US | claimed |
| WO-2024197069-A2 | THYROCYTES AND USES THEREOF | LIFENET HEALTH (US) | 2024-09-26 | — | — | WO | claimed |
| EP-4381107-A2 | A METHOD OF DETECTING A THYROID BIOMARKER | Agency for Science, Technology and Research (SG) | 2024-06-12 | — | — | EP | claimed |
| US-20240101963-A1 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-03-28 | — | — | US | claimed |
| CN-114609266-B | Application of marker in preparation of diagnostic reagent for thyroid related diseases | 徐州医科大学 | 2023-03-24 | — | — | CN | claimed |
| WO-2023014304-A2 | A METHOD OF DETECTING A THYROID BIOMARKER | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-02-09 | — | — | WO | claimed |
| CN-114609265-B | Method for detecting eight thyroid hormone markers in serum by liquid chromatography tandem mass spectrometry technology | 徐州医科大学 | 2023-01-24 | — | — | CN | claimed |
| CN-114609265-A | Method for detecting eight thyroid hormone markers in serum by liquid chromatography tandem mass spectrometry technology | 徐州医科大学 | 2022-06-10 | — | — | CN | claimed |
| CN-114609266-A | Application of marker in preparation of diagnostic reagent for thyroid related diseases | 徐州医科大学 | 2022-06-10 | — | — | CN | claimed |
| US-4399121-A | Iodothyronine immunogens and antibodies | MILES LABORATORIES, INC. (US) | 1983-08-16 | — | — | US | claimed |
| EP-0079489-A1 | Methotrexate-labeled iodothyronine conjugates and method, reagent means and test device for the determination of iodothyronine in or iodothyronine uptake of a liquid sample | MILES LABORATORIES, INC. (US) | 1983-05-25 | — | — | EP | claimed |
| EP-0078952-A1 | N-aminoalkyl iodothyronine derivatives, iodothyronine immunogens and antibodies | MILES LABORATORIES, INC. (US) | 1983-05-18 | — | — | EP | claimed |
| EP-0078477-A2 | Fenclofenac as TBP blocking agent in iodothyronine immunoassays | MILES LABORATORIES, INC. (US) | 1983-05-11 | — | — | EP | claimed |
| EP-0073865-A1 | Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds | AMERSHAM INTERNATIONAL plc (GB) | 1983-03-16 | — | — | EP | claimed |
| US-4376165-A | Method of preparing an enzyme-labeled ligand for use in specific binding assays and the labeled conjugate produced thereby | MILES LABORATORIES, INC. (US) | 1983-03-08 | — | — | US | claimed |
| US-4358604-A | ANTIBODIES-USEFUL IN IMMUNOASSAY | MILES LABORATORIES, INC. (US) | 1982-11-09 | — | — | US | claimed |
| US-4331808-A | Chemiluminescent naphthalene-1,2-dicarboxylic acid hydrazide-labeled haptens | MILES LABORATORIES, INC. (US) | 1982-05-25 | — | — | US | claimed |
| US-4238565-A | Specific binding assay with a prosthetic group as a label component | MILES LABORATORIES, INC. (US) | 1980-12-09 | — | — | US | claimed |
| US-4213893-A | Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays | MILES LABORATORIES, INC. (US) | 1980-07-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101963-A1 | SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME | IAPP, ALPG, PNLIP | FOLH1 1317/4885NAALAD2 3573/4885MME 1848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.